-
Intimate Bridge 2 Conception developing an OTC take-home insemination device
PITTSBURGH — A private entrepreneur is close to introducing a take-home intracervical insemination fertilization kit to retail, according to a story published in the Pittsburgh Post-Gazette Friday. The product will be submitted for Food and Drug Administration approval in the first half of 2011. If approved, Steve Bollinger first plans to introduce the product into doctor’s offices before launching through retail pharmacy.
-
Alimera reports positive results of phase-3 study for Iluvien
ATLANTA — A drug designed to treat an eye condition caused by diabetes may provide a long-term option for patients, according to Alimera Sciences.
Alimera said in two three-year, phase-3 pivotal clinical trials — collectively known as the FAME Study — of Iluvien, which is designed to treat diabetic macular edema, the drug improved visual acuity among patients.